Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for EDAP TMS S.A. (EDAP : NSDQ)
 
 • Company Description   
EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors.

Number of Employees: 227

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.18 Daily Weekly Monthly
20 Day Moving Average: 73,009 shares
Shares Outstanding: 33.47 (millions)
Market Capitalization: $240.29 (millions)
Beta: 1.34
52 Week High: $7.88
52 Week Low: $5.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.97% 11.53%
12 Week -0.42% 9.47%
Year To Date 19.87% 51.76%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine
-
Vaulx-en-Velin,I0 69120
FRA
ph: 33-04-72-15-31-50
fax: 33-04-72-15-31-51
jfraunces@lifesciadvisors.com http://www.edap-tms.com
 
 • General Corporate Information   
Officers
Marc Oczachowski - Chief Executive Officer and Chairman
Frederic Pech - Chief Operating Officer
Francois Dietsch - Chief Financial Officer
Marie Meynadier - Independent Director
Pierre Beysson - Independent Director

Peer Information
EDAP TMS S.A. (ABMD)
EDAP TMS S.A. (DMDS)
EDAP TMS S.A. (CPWY.)
EDAP TMS S.A. (EQUR)
EDAP TMS S.A. (ECIA)
EDAP TMS S.A. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 268311107
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/24/22
Share - Related Items
Shares Outstanding: 33.47
Most Recent Split Date: (:1)
Beta: 1.34
Market Capitalization: $240.29 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.08 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/24/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.27
Price/Cash Flow: 77.59
Price / Sales: 4.45
EPS Growth
vs. Year Ago Period: -66.67%
vs. Previous Quarter: -75.00%
Sales Growth
vs. Year Ago Period: 17.64%
vs. Previous Quarter: -8.69%
ROE
03/31/22 - 0.44
12/31/21 - 1.53
09/30/21 - 0.36
ROA
03/31/22 - 0.29
12/31/21 - 0.95
09/30/21 - 0.21
Current Ratio
03/31/22 - 4.38
12/31/21 - 3.75
09/30/21 - 4.34
Quick Ratio
03/31/22 - -
12/31/21 - 3.34
09/30/21 - 3.77
Operating Margin
03/31/22 - 0.47
12/31/21 - 1.51
09/30/21 - 0.29
Net Margin
03/31/22 - 0.47
12/31/21 - 1.51
09/30/21 - 0.29
Pre-Tax Margin
03/31/22 - 0.87
12/31/21 - 2.03
09/30/21 - 1.17
Book Value
03/31/22 - 1.68
12/31/21 - 1.77
09/30/21 - 1.67
Inventory Turnover
03/31/22 - 3.38
12/31/21 - 3.13
09/30/21 - 3.18
Debt-to-Equity
03/31/22 - 0.12
12/31/21 - 0.11
09/30/21 - 0.14
Debt-to-Capital
03/31/22 - 10.73
12/31/21 - 9.67
09/30/21 - 12.01
 

Powered by Zacks Investment Research ©